✦ LIBER ✦

New Insulin Glargine 300 U/mL: Glycemic Control and Hypoglycemia in a Meta-Analysis of Phase 3a EDITION Clinical Trials in People with T2DM

✍ Scribed by Hramiak, Irene; Ritzel, Robert; Roussel, Ronan; Bolli, Geremia B.; Vinet, Laetitia; Yki-Järvinen, Hannele

Book ID: 126875187
Publisher: Canadian Diabetes Association
Year: 2014
Tongue: English
Weight: 50 KB
Volume: 38
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2014.07.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New Insulin Glargine 300 U/mL: Glycemic

New Insulin Glargine 300 U/mL: Glycemic Control and Hypoglycemia in Insulin-Naïve People with T2DM (EDITION 3)

✍ Bajaj, Harpreet S.; Bolli, Geremia B.; Riddle, Matthew C.; Bergenstal, Richard; 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 75 KB

Sustained Glycemic Control and Less Hypo

Sustained Glycemic Control and Less Hypoglycemia with New Insulin Glargine 300 U/mL Compared with 100 U/mL: 1-Year Results in People with T2DM Using Basal + Mealtime Insulin (EDITION 1)

✍ Leiter, Lawrence A.; Riddle, Matthew C.; Bolli, Geremia B.; Yki-Järvinen, Hannel 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 190 KB

Less Nocturnal Hypoglycemia and Weight G

Less Nocturnal Hypoglycemia and Weight Gain with New Insulin Glargine 300 U/mL Compared with 100 U/mL: 1-Year Results in People with T2DM Using Basal Insulin with OADs (EDITION 2)

✍ Goldenberg, Ronald; Yki-Järvinen, Hannele; Bergenstal, Richard M.; Bolli, Geremi 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 197 KB

Subjects Achieving Good Glycemic Control

Subjects Achieving Good Glycemic Control (HbA1c<7.0%) Experience a Lower Rate of Confirmed and Nocturnal-Confirmed Hypoglycemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase 3a Trials

✍ Einhorn, Daniel; Handelsman, Yehuda; Bode, Bruce W.; Endahl, Lars; Mersebach, He 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 59 KB

Insulin degludec improves health-related

Insulin degludec improves health-related quality of life (SF-36 ® ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials

✍ Freemantle, N.; Meneghini, L.; Christensen, T.; Wolden, M. L.; Jendle, J.; Ratne 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Lower Rates in Overall and Nocturnal Hyp

Lower Rates in Overall and Nocturnal Hypoglycemia of Insulin Degludec vs. Insulin Glargine with Treatment Intensification in T2DM in Moderately Good Control (A1c 7.5–8.5%) at Baseline: A Meta-Analysis

✍ Garber, Alan J.; Colagiuri, Stephen; Rodbard, Helena W.; Milosevski, Victor; Las 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 52 KB